6887 — Sunshine Lake Pharma Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$22.99bn
- HK$26.65bn
- CNY4.82bn
Annual balance sheet for Sunshine Lake Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 1,262 | 1,920 | 1,485 | 1,503 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 2,274 | 2,018 | 1,894 | 1,892 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 4,151 | 6,412 | 4,979 | 4,651 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 4,003 | 4,180 | 4,391 | 4,310 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 10,689 | 12,658 | 11,932 | 11,993 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 8,958 | 6,178 | 4,814 | 6,038 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 14,378 | 12,330 | 11,587 | 7,648 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | -3,689 | 328 | 344 | 4,345 |
| Total Liabilities & Shareholders' Equity | 10,689 | 12,658 | 11,932 | 11,993 |
| Total Common Shares Outstanding |